ANRO

NYSE · Equity

Alto Neuroscience, Inc.

US Healthcare Biotechnology

Latest week
29 May 2026
Close
20.070000
Fair value
10.384215
Expectation
Positive 55.84%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
20.07
12-Week Change
-9.84%
Trend Signal
Active
Expectation
Positive 55.84%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
42.62
Market Dynamics
-0.02

Over the latest 12 completed weeks ending 2026-05-29, ANRO fell 9.84%, moving from 22.26 to 20.07. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 42.62 and has softened across the 12-week window. Market Dynamics is -0.02 on the latest week. Expectation is positive at 55.84%.